KAYLAN LANCASTER: Open Payments
NPI 1689158446 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 52 payments from 18 companies in 2025. Trend: 2023 $1,330 · 2024 $995 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $246 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $140 |
| Lilly USA, LLC | 7 | $131 |
| Dexcom, Inc. | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| PFIZER INC. | 3 | $60 |
| Exact Sciences Corporation | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Corcept Therapeutics | 2 | $39 |
Products named: JARDIANCE, Ozempic, ELIQUIS, Dexcom G6 Transmitter, Kerendia, Cologuard Collection Kit, TRINTELLIX, Korlym.
Industry payments across GA — which companies pay providers there.
